Susquehanna International Group’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$41.2M Sell
2,457,134
-1,172,528
-32% -$19.7M 0.01% 227
2025
Q1
$55.8M Buy
3,629,662
+3,570,976
+6,085% +$54.9M 0.01% 145
2024
Q4
$1.29M Sell
58,686
-467,183
-89% -$10.3M ﹤0.01% 2613
2024
Q3
$9.48M Buy
525,869
+434,282
+474% +$7.83M ﹤0.01% 669
2024
Q2
$1.49M Sell
91,587
-996,666
-92% -$16.2M ﹤0.01% 2079
2024
Q1
$15.4M Buy
1,088,253
+930,822
+591% +$13.1M ﹤0.01% 459
2023
Q4
$1.64M Sell
157,431
-1,097,071
-87% -$11.5M ﹤0.01% 2154
2023
Q3
$12.8M Sell
1,254,502
-2,520,696
-67% -$25.7M ﹤0.01% 598
2023
Q2
$28.4M Buy
3,775,198
+644,036
+21% +$4.85M 0.01% 303
2023
Q1
$27.7M Sell
3,131,162
-141,086
-4% -$1.25M 0.01% 331
2022
Q4
$29.8M Buy
3,272,248
+55,525
+2% +$506K 0.01% 236
2022
Q3
$26M Sell
3,216,723
-1,364,602
-30% -$11M 0.01% 217
2022
Q2
$34.5M Sell
4,581,325
-1,167,234
-20% -$8.78M 0.01% 199
2022
Q1
$54M Sell
5,748,559
-5,192,292
-47% -$48.8M 0.01% 191
2021
Q4
$87.6M Buy
10,940,851
+15,889
+0.1% +$127K 0.01% 126
2021
Q3
$106M Buy
10,924,962
+437,907
+4% +$4.27M 0.01% 138
2021
Q2
$104M Buy
10,487,055
+1,933,435
+23% +$19.1M 0.01% 142
2021
Q1
$98.7M Buy
8,553,620
+1,602,210
+23% +$18.5M 0.02% 135
2020
Q4
$67.1M Buy
6,951,410
+2,448,516
+54% +$23.6M 0.01% 157
2020
Q3
$40.6M Sell
4,502,894
-3,136,484
-41% -$28.3M 0.01% 185
2020
Q2
$94.2M Buy
7,639,378
+1,060,915
+16% +$13.1M 0.02% 76
2020
Q1
$59.1M Sell
6,578,463
-90,425
-1% -$812K 0.02% 93
2019
Q4
$65.4M Buy
6,668,888
+495,043
+8% +$4.85M 0.02% 118
2019
Q3
$42.5M Buy
6,173,845
+1,306,927
+27% +$8.99M 0.01% 133
2019
Q2
$44.9M Buy
4,866,918
+1,453,617
+43% +$13.4M 0.02% 137
2019
Q1
$53.5M Buy
+3,413,301
New +$53.5M 0.02% 83
2018
Q4
Hold
0
4815
2018
Q3
Hold
0
4631
2018
Q2
Sell
-457,315
Closed -$7.82M 4664
2018
Q1
$7.82M Sell
457,315
-596,985
-57% -$10.2M ﹤0.01% 368
2017
Q4
$20M Sell
1,054,300
-5,450,711
-84% -$103M 0.01% 204
2017
Q3
$114M Buy
6,505,011
+3,429,987
+112% +$60.4M 0.04% 47
2017
Q2
$102M Sell
3,075,024
-676,443
-18% -$22.5M 0.04% 44
2017
Q1
$120M Sell
3,751,467
-27,518
-0.7% -$883K 0.06% 37
2016
Q4
$137M Buy
3,778,985
+434,552
+13% +$15.8M 0.07% 18
2016
Q3
$154M Buy
3,344,433
+1,139,241
+52% +$52.4M 0.07% 20
2016
Q2
$111M Buy
2,205,192
+582,769
+36% +$29.3M 0.06% 24
2016
Q1
$86.8M Buy
1,622,423
+1,387,478
+591% +$74.2M 0.05% 58
2015
Q4
$15.4M Sell
234,945
-856,825
-78% -$56.2M 0.01% 313
2015
Q3
$61.6M Sell
1,091,770
-321,415
-23% -$18.1M 0.03% 99
2015
Q2
$83.5M Buy
1,413,185
+927,932
+191% +$54.8M 0.04% 96
2015
Q1
$30.2M Buy
485,253
+380,039
+361% +$23.7M 0.01% 199
2014
Q4
$6.05M Sell
105,214
-1,202,584
-92% -$69.2M ﹤0.01% 867
2014
Q3
$70.3M Buy
1,307,798
+302,181
+30% +$16.2M 0.03% 106
2014
Q2
$52.7M Sell
1,005,617
-1,644,114
-62% -$86.2M 0.02% 146
2014
Q1
$140M Sell
2,649,731
-1,103,754
-29% -$58.3M 0.06% 48
2013
Q4
$150M Buy
3,753,485
+1,024,680
+38% +$41.1M 0.07% 41
2013
Q3
$103M Buy
2,728,805
+238,760
+10% +$9.02M 0.05% 61
2013
Q2
$97.6M Buy
+2,490,045
New +$97.6M 0.06% 56